Search Results - "Dain, J G"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Biotransformation of Clozapine in Humans by DAIN, J. G, NICOLETTI, J, BALLARD, F

    Published in Drug metabolism and disposition (01-05-1997)
    “…The metabolic pathways of clozapine (CZ, Clozaril (Novartis Pharmaceuticals Corporation, East Hanover, NJ),…”
    Get full text
    Journal Article
  2. 2

    Biotransformation of fluvastatin sodium in humans by Dain, J G, Fu, E, Gorski, J, Nicoletti, J, Scallen, T J

    Published in Drug metabolism and disposition (01-07-1993)
    “…The metabolic pathways of fluvastatin sodium (FV; Lescol, Sandoz compound XU 62-320), [R*,S*-(E)]-(+-)-sodium-3,5-dihydroxy-7-[3-…”
    Get more information
    Journal Article
  3. 3

    Reduction in Glucose Levels in STZ Diabetic Rats by 4-(2,2-Dimethyl-1-oxopropyl)benzoic Acid:  A Prodrug Approach for Targeting the Liver by Bebernitz, Gregory R, Dain, Jeremy G, Deems, Rhonda O, Otero, Dario A, Simpson, W. Ronald, Strohschein, Robert J

    Published in Journal of medicinal chemistry (15-02-2001)
    “…The overproduction of glucose by the liver in NIDDM patients markedly contributes to their fasting hyperglycemia and is a direct consequence of the increased…”
    Get full text
    Journal Article
  4. 4

    Hypoglycemic Prodrugs of 4-(2,2-Dimethyl-1-oxopropyl)benzoic Acid by Aicher, Thomas D, Bebernitz, Gregory R, Bell, Philip A, Brand, Leonard J, Dain, Jeremy G, Deems, Rhonda, Fillers, William S, Foley, James E, Knorr, Douglas C, Nadelson, Jeffrey, Otero, Dario A, Simpson, Ronald, Strohschein, Robert J, Young, Douglas A

    Published in Journal of medicinal chemistry (14-01-1999)
    “…SAH 51-641 (1) is a potent hypoglycemic agent, which acts by inhibiting hepatic gluconeogenesis. It is a prodrug of 4-(2,2-dimethyl-1-oxopropyl)benzoic acid…”
    Get full text
    Journal Article
  5. 5

    Metabolic pathways of 4-[(3-methoxyphenyl)methyl]-2,2,6,6-tetramethyl-1-oxa-4-aza-2,6- disilacyclohexane (MPSC) hydrochloride, a silicon-containing xenobiotic, in rat, dog, and man by Dain, J G, Nicoletti, J

    Published in Xenobiotica (01-09-1995)
    “…1. The metabolic pathways of Sandoz compound 58-112, 4-[(3-methyoxyphenyl)-methyl]-2,2,6,6-tetramethyl-1-oxa-4-aza-2,6- disilacyclohexane (MPSC) hydrochloride…”
    Get more information
    Journal Article
  6. 6

    Effect of diet and gavage on the absorption and metabolism of fluperlapine in the rat by Dain, J G, Jaffe, J M

    Published in Drug metabolism and disposition (01-03-1988)
    “…Fluperlapine, Sandoz compound NB 106-689, 3-fluoro-6-(4-methyl-1-piperazinyl)-11H-dibenz[b,e]azepine, in a 12-week toxicity study exhibited liver toxicity…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog by Dain, J G, Bhuta, S I, Coombs, R A, Talbot, K C, Dugger, H A

    Published in Drug metabolism and disposition (01-07-1980)
    “…Butalbital, 5-allyl-5-isobutylbarbituric acid, labeled in the 2-position with 14C, was administered to dogs. Ninety-two percent of the radioactivity of the…”
    Get more information
    Journal Article
  9. 9

    Disposition of [3H]fluvastatin following single oral doses in beagle dogs and rhesus monkeys with bile fistulae by Tse, F L, Dain, J G, Kalafsky, G

    Published in Biopharmaceutics & drug disposition (01-04-1995)
    “…The disposition of [3H]fluvastatin was examined following single oral doses in dogs (12.4 mg kg-1) and monkeys (0.48 and 45.5 mg kg-1) with bile fistulae…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Pharmacokinetics and metabolism of alpha-[(dimethylamino)methyl]-2- (3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol, a hypoglycemic agent, in man by Tse, F L, Orwig, B A, Jaffe, J M, Dain, J G

    Published in Xenobiotica (01-10-1987)
    “…1. The pharmacokinetics and metabolism of alpha-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl) -1H-[3-14C]indole-3-methanol, a new hypoglycemic…”
    Get more information
    Journal Article
  13. 13

    Pharmacokinetics of compound 58-112, a potential skeletal muscle relaxant, in man by Tse, F L, Jaffe, J M, Dain, J G

    Published in Journal of clinical pharmacology (01-01-1984)
    “…The pharmacokinetics of 4-[(3-methoxyphenyl)methyl] -2,2,6,6-tetramethyl-1-oxa-4-aza-2,6-disilacyclohexane (Sandoz compound 58-112), a new chemical entity with…”
    Get more information
    Journal Article
  14. 14
  15. 15